Bernd R. Seizinger - Net Worth and Insider Trading
Bernd R. Seizinger Net Worth
The estimated net worth of Bernd R. Seizinger is at least $215,770 dollars as of 2024-05-16. Bernd R. Seizinger is the Director of Aprea Therapeutics Inc and owns about 33,685 shares of Aprea Therapeutics Inc (APRE) stock worth over $195,710. Bernd R. Seizinger is also the Director of Aptose Biosciences Inc and owns about 17,000 shares of Aptose Biosciences Inc (APTO) stock worth over $20,060. Details can be seen in Bernd R. Seizinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bernd R. Seizinger has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).
Transaction Summary of Bernd R. Seizinger
Bernd R. Seizinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bernd R. Seizinger owns 2 companies in total, including Aprea Therapeutics Inc (APRE) , and Aptose Biosciences Inc (APTO) .
Click here to see the complete history of Bernd R. Seizinger’s form 4 insider trades.
Insider Ownership Summary of Bernd R. Seizinger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2024-03-13 | director |
| APTO | Aptose Biosciences Inc | 2023-09-22 | director |
Bernd R. Seizinger Latest Holdings Summary
Bernd R. Seizinger currently owns a total of 2 stocks. Among these stocks, Bernd R. Seizinger owns 33,685 shares of Aprea Therapeutics Inc (APRE) as of March 13, 2024, with a value of $195,710 and a weighting of 90.7%. Bernd R. Seizinger also owns 17,000 shares of Aptose Biosciences Inc (APTO) as of September 22, 2023, with a value of $20,060 and a weighting of 9.3%.
Latest Holdings of Bernd R. Seizinger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2024-03-13 | 33,685 | 5.81 | 195,710 |
| APTO | Aptose Biosciences Inc | 2023-09-22 | 17,000 | 1.18 | 20,060 |
Holding Weightings of Bernd R. Seizinger
Bernd R. Seizinger Form 4 Trading Tracker
According to the SEC Form 4 filings, Bernd R. Seizinger has made a total of 3 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 6,860 shares on March 13, 2024, which cost Bernd R. Seizinger around $50,009.
According to the SEC Form 4 filings, Bernd R. Seizinger has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 17,000 shares on September 22, 2023, which cost Bernd R. Seizinger around $53,380.
Insider Trading History of Bernd R. Seizinger
- 1
Bernd R. Seizinger Trading Performance
GuruFocus tracks the stock performance after each of Bernd R. Seizinger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bernd R. Seizinger is 9.29%. GuruFocus also compares Bernd R. Seizinger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bernd R. Seizinger within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bernd R. Seizinger's insider trading performs compared to the benchmark.
Performance of Bernd R. Seizinger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.34 | | | | | |
| Relative Return to S&P 500(%) | -1.77 | | | | | |
Bernd R. Seizinger Ownership Network
Bernd R. Seizinger Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Bernd R. Seizinger is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Bernd R. Seizinger made 2 insider transaction in Aprea Therapeutics Inc (APRE) with a net purchase of 16,957. Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 6,860 shares made by Henneman John B Iii , a net purchase of 2,000 shares made by Oren Gilad , and a net purchase of 1,010 shares made by John P. Hamill .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Bernd R. Seizinger Mailing Address
Above is the net worth, insider trading, and ownership report for Bernd R. Seizinger. You might contact Bernd R. Seizinger via mailing address: 535 Boylston Street, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
